CA3182748A1 - Ve-ptp inhibitors - Google Patents
Ve-ptp inhibitorsInfo
- Publication number
- CA3182748A1 CA3182748A1 CA3182748A CA3182748A CA3182748A1 CA 3182748 A1 CA3182748 A1 CA 3182748A1 CA 3182748 A CA3182748 A CA 3182748A CA 3182748 A CA3182748 A CA 3182748A CA 3182748 A1 CA3182748 A1 CA 3182748A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- compound according
- unsubstituted
- previous
- immediately previous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063039764P | 2020-06-16 | 2020-06-16 | |
| US63/039,764 | 2020-06-16 | ||
| PCT/US2021/037714 WO2021257754A1 (en) | 2020-06-16 | 2021-06-16 | Small molecule ve-ptp inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3182748A1 true CA3182748A1 (en) | 2021-12-23 |
Family
ID=79268399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3182748A Pending CA3182748A1 (en) | 2020-06-16 | 2021-06-16 | Ve-ptp inhibitors |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4164690A1 (enExample) |
| JP (1) | JP2023530457A (enExample) |
| CN (1) | CN117460743A (enExample) |
| AU (1) | AU2021292526A1 (enExample) |
| CA (1) | CA3182748A1 (enExample) |
| WO (1) | WO2021257754A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7795444B2 (en) * | 2006-06-27 | 2010-09-14 | Warner Chilcott Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| US9096555B2 (en) * | 2009-01-12 | 2015-08-04 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome |
| ES2726946T3 (es) * | 2009-07-06 | 2019-10-10 | Aerpio Therapeutics Inc | Derivados de benzosulfonamida, composiciones de los mismos y su uso en la prevención de la metástasis de las células cancerosas |
| GB2516561B (en) * | 2013-03-15 | 2016-03-09 | Aerpio Therapeutics Inc | Compositions, formulations and methods for treating ocular diseases |
-
2021
- 2021-06-16 JP JP2022577587A patent/JP2023530457A/ja active Pending
- 2021-06-16 EP EP21825008.2A patent/EP4164690A1/en not_active Withdrawn
- 2021-06-16 CA CA3182748A patent/CA3182748A1/en active Pending
- 2021-06-16 WO PCT/US2021/037714 patent/WO2021257754A1/en not_active Ceased
- 2021-06-16 AU AU2021292526A patent/AU2021292526A1/en not_active Abandoned
- 2021-06-16 CN CN202180050398.8A patent/CN117460743A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023530457A (ja) | 2023-07-18 |
| CN117460743A (zh) | 2024-01-26 |
| AU2021292526A1 (en) | 2023-02-16 |
| WO2021257754A1 (en) | 2021-12-23 |
| EP4164690A1 (en) | 2023-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI360539B (en) | 3-carbamoyl-2-pyridone derivatives | |
| CA3095451C (en) | Ox2r compounds | |
| EP2297110B1 (en) | Indane derivatives as ampa receptor modulators | |
| JP2024534801A (ja) | サイロシンのプロドラッグ及び誘導体ならびにその使用 | |
| EP1820504A1 (en) | Imine compound | |
| CN115403570B (zh) | μ-阿片受体激动剂及其制备方法和在医药领域的应用 | |
| KR20170082577A (ko) | 치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도 | |
| NZ539095A (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
| CA2981404A1 (en) | Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds | |
| AU2016336437A1 (en) | Compounds, compositions, and methods for modulating CFTR | |
| EP1341771A2 (en) | Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors | |
| WO1998056757A1 (fr) | Derives de benzylamine | |
| TW200909400A (en) | Novel sulfonyl malonamide derivative and pharmaceutical use thereof | |
| CA3035999C (en) | Benzene fused heterocyclic derivatives and pharmaceutical composition comprising the same | |
| EP2771332B1 (en) | Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS | |
| KR20210024588A (ko) | 프로테아좀 활성 증진 화합물 | |
| AU2010233694A1 (en) | Indane derivatives | |
| CN112513011B (zh) | 苯衍生物 | |
| WO2001094309A1 (en) | Drug composition antagonistic to both pgd2/txa2 receptors | |
| FR2891828A1 (fr) | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique | |
| RO108869B1 (ro) | DERIVATI DE 6-ARIL-5,6-DIHIDROIMIDAZO-/2,1-b/-TIAZOL, PROCEDEU PENTRU PREPARAREA LOR SI INTERMEDIARI PENTRU REALIZAREA ACESTORA | |
| JP2002522423A (ja) | α１Ａ作動薬としてのイミダゾール及び関連化合物 | |
| US20120252853A1 (en) | Positive allosteric modulators of nicotinic acetylcholine receptor | |
| JP6454413B2 (ja) | アミノスルホニル系化合物、その製造方法、および使用 | |
| AU2012352572A1 (en) | Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251210 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260204 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260210 |